US Patent Issued to TANABE PHARMA on June 30 for "Prophylactic or therapeutic agent for porphyria" (Japanese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,563, issued on June 30, was assigned to TANABE PHARMA Corp. (Osaka, Japan).

"Prophylactic or therapeutic agent for porphyria" was invented by Tsuyoshi Suzuki (Osaka, Japan), Masahiro Kondo (Osaka, Japan), Fumihiro Takahashi (Osaka, Japan), Akihito Ogasawara (Osaka, Japan) and Kazumi Hyoudou (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A medicament for treatment or prevention of porphyria, comprising 1-{2-[(3S,4R)-1-{[(3R,4R)-1-cyclopentyl-3-fluoro-4-(4-methoxyphenyl)pyrrolidin-3-yl]carbonyl}-4-(methoxymethyl)pyrrolidin-3-yl]-5-(trifluoromethyl)phenyl}piperidine-4-carboxylic acid or a pharmaceutically acceptable salt or cocrystal ther...